Kalia Health

Redefining how preeclampsia is detected.

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location New York, NY, USA
  • Currency USD
  • Founded March 2018
  • Employees 2
  • Incorporation Type C-corp
  • Website kaliahealth.com

Company Summary

Preeclampsia is a leading cause of maternal mortality, affecting 21.3M pregnancies a year, yet diagnosis is inaccurate, inaccessible, and symptom-dependent. We are developing a rapid, low-cost, non-invasive, urine-based point-of-care test that works like a home pregnancy test. Two biomarker studies confirm diagnostic potential, our prototype is patented, and we are raising a seed round to complete R&D, secure FDA approval, and commercialize.

Team

  • Denali Dahl
    Chief Executive Officer

    Denali Dahl, PhD, CEO & Co-Founder
    Translational biomedical engineer building women's health technology. PhD in Biomedical Engineering, MSc in Global Health. 10+ years of clinical and technical research in female reproductive health across the U.S., Uganda, Nigeria, and Peru, with hands-on experience managing CROs and clinical study operations.

  • Happy Ghosh
    Chief Product Officer

    Biomedical engineer and product strategist focused on global healthcare access. 12+ years developing and assessing medical devices in the U.S. and Tanzania, with expertise in health policy, community research, and market development in low-resource settings.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free